Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women
Conditions:   Transgenderism;   Gender Identity;   Vascular Stiffness;   Vascular Inflammation;   Insulin Sensitivity;   Blood Pressure;   Lipid Disorder;   Appetitive Behavior Intervention:   Sponsors:   University of Colorado, Denver;   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy
Condition:   Prostate Cancer Interventions:   Other: Focus group creation;   Other: Workshop Sponsor:   Centre Hospitalier Universitaire de NÄ«mes Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2019 Category: Research Source Type: clinical trials